BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12215888)

  • 1. Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy.
    Oshima Y; Sakamoto T; Hisatomi T; Tsutsumi C; Ueno H; Ishibashi T
    Gene Ther; 2002 Sep; 9(18):1214-20. PubMed ID: 12215888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis.
    Sakamoto T; Ueno H; Sonoda K; Hisatomi T; Shimizu K; Ohashi H; Inomata H
    Gene Ther; 2000 Nov; 7(22):1915-24. PubMed ID: 11127579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene.
    Haiping Z; Takayama K; Uchino J; Harada A; Adachi Y; Kura S; Caicun Z; Tsuzuki T; Nakanishi Y
    Cancer Gene Ther; 2006 Sep; 13(9):864-72. PubMed ID: 16710346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
    Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
    Kon CH; Occleston NL; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic amelioration of fibroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-beta) receptor mediated by adenoviral vector.
    Nishioka A; Ogawa Y; Mima T; Jin YJ; Sonobe H; Kariya S; Kubota K; Yoshida S; Ueno H
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1235-41. PubMed ID: 15001268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy.
    Bochaton-Piallat ML; Kapetanios AD; Donati G; Redard M; Gabbiani G; Pournaras CJ
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2336-42. PubMed ID: 10892881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.
    Chung IM; Ueno H; Pak YK; Kim JW; Choi DH; Shin GJ; Yang WI; Jang Ys
    Exp Mol Med; 2002 Sep; 34(4):299-307. PubMed ID: 12515396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy.
    Ozawa S; Uchiyama K; Nakamori M; Ueda K; Iwahashi M; Ueno H; Muragaki Y; Ooshima A; Yamaue H
    Surgery; 2006 Apr; 139(4):563-73. PubMed ID: 16627068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor.
    Ikuno Y; Leong FL; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3107-16. PubMed ID: 10967071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy.
    Guo L; Yu W; Li X; Zhao G; Liang J; He P; Wang K; Zhou P; Jiang Y; Zhao M
    Exp Eye Res; 2008 Dec; 87(6):551-60. PubMed ID: 18926819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.
    Nakamura T; Sakata R; Ueno T; Sata M; Ueno H
    Hepatology; 2000 Aug; 32(2):247-55. PubMed ID: 10915731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Müller cells.
    Sakamoto T; Ueno H; Goto Y; Oshima Y; Ishibashi T; Inomata H
    Gene Ther; 1998 Aug; 5(8):1088-97. PubMed ID: 10326032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy.
    Nakagawa M; Refojo MF; Marin JF; Doi M; Tolentino FI
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling].
    Liu W; Chua CH; Wu XL; Wang DR; Yin DM; Cui L; Cao YL; Longaker MT
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):31-6. PubMed ID: 12757642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy.
    Andrews A; Balciunaite E; Leong FL; Tallquist M; Soriano P; Refojo M; Kazlauskas A
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2683-9. PubMed ID: 10509666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electron-immunostaining characteristics of platelet-derived growth factor, transforming growth factor beta1 and their receptors in epiretinal membranes].
    Wang F; Xu X; Zhang X; Yan Y
    Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):369-71, 24. PubMed ID: 11853632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.
    Connor TB; Roberts AB; Sporn MB; Danielpour D; Dart LL; Michels RG; de Bustros S; Enger C; Kato H; Lansing M
    J Clin Invest; 1989 May; 83(5):1661-6. PubMed ID: 2708527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.